Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph

Kód výsledku v IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00209805%3A_____%2F12%3A%230000345" target="_blank" >RIV/00209805:_____/12:#0000345 - isvavai.cz</a>

Výsledek na webu

<a href="http://link.springer.com/article/10.1007%2Fs00432-012-1279-y" target="_blank" >http://link.springer.com/article/10.1007%2Fs00432-012-1279-y</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1007/s00432-012-1279-y" target="_blank" >10.1007/s00432-012-1279-y</a>

Jazyk výsledku

angličtina

Název v původním jazyce

Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph

Popis výsledku v původním jazyce

Background: We have recently reported from Epilymph, a multicentre case-control study of lymphoma conducted in six European countries, a significant association between NHL and self-reported history of past or present HBV infection based on questionnairedata from face-to-face interviews. Methods: To corroborate this observation, we used the data and blood specimen from Epilymph to investigate the associations between serological indicators of HBV infection with risk of Hodgkin lymphoma, non-Hodgkin lymphoma (NHL) and specific lymphoma entities. For 1,518 cases and 1,496 controls with sufficient amount of serum or plasma, we tested HBs-antigen, anti-HBc and anti-HBs to distinguish between current or past infection and immunity by vaccination. Statistical analysis was carried out with unconditional logistic regression. Results: We found a positive association of a past HBV infection with multiple myeloma (MM, OR = 1.97, 95 % CL = 1.16-3.37). Non-significant associations were found betwe

Název v anglickém jazyce

Hepatitis B virus infection and risk of lymphoma: results of a serological analysis within the European case-control study Epilymph

Popis výsledku anglicky

Background: We have recently reported from Epilymph, a multicentre case-control study of lymphoma conducted in six European countries, a significant association between NHL and self-reported history of past or present HBV infection based on questionnairedata from face-to-face interviews. Methods: To corroborate this observation, we used the data and blood specimen from Epilymph to investigate the associations between serological indicators of HBV infection with risk of Hodgkin lymphoma, non-Hodgkin lymphoma (NHL) and specific lymphoma entities. For 1,518 cases and 1,496 controls with sufficient amount of serum or plasma, we tested HBs-antigen, anti-HBc and anti-HBs to distinguish between current or past infection and immunity by vaccination. Statistical analysis was carried out with unconditional logistic regression. Results: We found a positive association of a past HBV infection with multiple myeloma (MM, OR = 1.97, 95 % CL = 1.16-3.37). Non-significant associations were found betwe

Druh

J_x - Nezařazeno - Článek v odborném periodiku (Jimp, Jsc a Jost)

CEP obor

FD - Onkologie a hematologie

OECD FORD obor

—

Projekt

—

Návaznosti

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Rok uplatnění

2012

Kód důvěrnosti údajů

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Název periodika

Journal of cancer research and clinical oncology

ISSN

0171-5216

e-ISSN

—

Svazek periodika

138

Číslo periodika v rámci svazku

12

Stát vydavatele periodika

US - Spojené státy americké

Počet stran výsledku

9

Strana od-do

1993-2001

Kód UT WoS článku

000310813200003

EID výsledku v databázi Scopus

—